Miller School of Medicine | University of Miami

Latest NewsCeremonial Wall-Breaking for the Lois Pope Center for Retinal and Macular Degeneration Research

From left, Eduardo C. Alfonso, M.D., Palm Beach Gardens Mayor Maria G. Marino, Julio Frenk, Lois Pope, and Henri R. Ford, M.D., MHA.

With hammers smashing through a fake brick wall, the opening of a first-of-its-kind center designed to bring an end to blinding eye disease moved a significant step closer to reality.

A ceremonial wall-breaking was held Dec. 14 at Bascom Palmer Eye Institute in Palm Beach Gardens to signal the beginning of construction of the Lois Pope Center for Retinal and Macular Degeneration Research. The center, which promises to serve as the hub for clinical care and research studies to battle age-related macular degeneration (AMD) and retinal diseases, is the result of a historic $12 million donation from philanthropist Lois Pope, the largest gift in Bascom Palmers history.

Stem cells (so-called master cells) are unique and important in the body because they can do almost anything, and scientists have only begun to discover their potential. Thats why researchers use of them has created controversy, attracting the attention of scientists, policymakers, and bioethicists across the globe. Stem cells can transform into any of the bodys more than 200 cell types.

Read more about the commentary

Sabrina Taldone, M.D., MBA, a chief resident in the Division of Internal Medicine at the University of Miami Miller School of Medicine. Having earned her undergraduate and graduate degrees from the University of Miami, Dr. Taldone saw the need for a health care administration elective and decided to do something about it.

Read more about the new elective

Employing advanced technology, innovative thinking, and some adaptive strategies, researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have discovered a way to identify combinations of available medications that could optimally treat people diagnosed with glioblastoma, the most common and deadliest form of primary adult brain cancer.

Read more about the study

In Dr. Jonathan Schatzs laboratory at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, researchers have pioneered a new use for CRISPR, the genomic editing tool at the center of much media attention.

Read more about CRISPR

Stephen L. Demers, senior vice president for ambulatory and clinical services at Lahey Hospital & Medical Center in Burlington, Massachusetts, will join UHealth the University of Miami Health System on January 21 as chief operating officer.

Read more about Stephen L. Demers

News & Events

Read the original here:

Miller School of Medicine | University of Miami

Related Post

Comments are closed.